Isofol Medical: A comeback story in the making
17 juni, 07:00
17 juni, 07:00
Redeye re-initiates coverage of Isofol Medical, a Swedish oncology biotech company targeting the multibillion-dollar colorectal cancer treatment market. With a renewed clinical strategy, strengthened financial backing, and strategic support from international partners, we see compelling upside potential as the company works to reestablish arfolitixorin as a next-generation treatment in metastatic colorectal cancer.
17 juni, 07:00
Redeye re-initiates coverage of Isofol Medical, a Swedish oncology biotech company targeting the multibillion-dollar colorectal cancer treatment market. With a renewed clinical strategy, strengthened financial backing, and strategic support from international partners, we see compelling upside potential as the company works to reestablish arfolitixorin as a next-generation treatment in metastatic colorectal cancer.
Börsen idag
Börsen idag
Börsen idag
Börsen idag
1 DAG %
Senast
Cint Group
Idag, 08:38
Teknisk analys: Positiva småbolag
Diös
Idag, 08:03
Diös ökar sitt förvaltningsresultat
SAS
Idag, 07:58
Air France-KLM ny majoritetsägare i SAS
OMX Stockholm 30
1 DAG %
Senast
2 529,50